A downstream effect of this sequestration of β-catenin by E-cadherin is wnt-β- catenin pathway inhibition[1] and this was further analyzed by a wnt pathway reporter assay in CLL specimens that were treated with MS-275. The gene discussed is CDH1; the disease is B-cell chronic lymphocytic leukemia.